Hutchmed (china) Share Discussion Threads

[nerdofsteel] 14/5/2019 07:12

I bought a significant number of shares yesterday because the Co's fundamentals have not changed. For any medicines approved in the U.S. such as Savolitinib, it will be a first or best-in-class and I can't see how any tariffs applied would reduce the demand for the product. President Trump has just done me a favour.

[shaker44] 13/5/2019 16:38

Down 24% in 4 weeks on USA market. Clearly not based on fundamentals. Looks a good buying opportunity

[dbadvn] 13/5/2019 16:13

Buying again at this level. Steeplejack is correct this fall is related to China trade talks and nothing to do with the fundamentals. As long as the long term story is intact I will stay in.

HK listing will effectively draw an end to the trade talk proxy in any case . Looks more and more like a shrewd move by management.

[nerdofsteel] 12/5/2019 15:57

ASCO abstracts including Savolitinib available this coming Wednesday

[nerdofsteel] 12/5/2019 08:58

For those very reasons I've switched to buying ADR's only now.

[steeplejack] 11/5/2019 17:59

GW Pharmaceuticals closed their AIM listing because they considered the Nasdaq a more educated market as far as biotech was concerned and thus a better market on which to raise finance.This was despite GWP being a U.K. domiciled company with a very British history.

It’s possible that HCM might step up to a full UK listing but I reckon that the same considerations that applied to GWPs thinking are relevant to HCM.Its more than likely that HCM will,in time,delist from AIM.There’s little traded volume and actually a lot of UK funds don’t invest in AIM stocks being outside of their defined remit.AIM is a pitifully unregulated market with only a few serious long term players who are conspicuous by their success.Frankly,AIM is not a listing for a top notch company like HCM.Should they really be sharing the same arena that has played host to companies like Quindell .


If HCM did delist,then it will be problem for PIs.You’d be offered stock in HK or the US but it’s all very fiddly and some brokers simply don’t facilitate the transfer.Nine times out of ten,you’ll end up selling to avoid complications and buying the stock afresh ,on Nasdaq or in Hong Kong,if so inclined.

[nerdofsteel] 11/5/2019 17:54

sportii, whilst there is a dircet link between the number of AIM Ordinary shares and ADR's on NASDAQ (dhortly to become 5 Ordinary shares = 1 ADR) I don't believe there will be any such link to HK listed shares as there is no mechanism to run a joint book between the two. So my understanding is this will be a separate standalone listing, however I would expect all 3 markets to value the Company in equilibrium.

[sportii] 11/5/2019 16:19

Nofs, thanks for the information.

Regarding forthcoming HKSE listing;
will the new shares to be listed on HKSE going to be ‘interlinked’ with AIM and NYSE listed shares?

Hope it will work out well for the company with a vastly increased investor numbers over a much wider geographical area.

[nerdofsteel] 11/5/2019 08:32

Sportii, I have previously asked a question at 2 AGM's about the London listing and the Board have been clear they will maintain it for the forseeable future, however that was prior to the HK listing announcement. I suspect it will remain for now, but in the long term I can see little point in maintaining it for the reasons I stated.

[grupo guitarlumber] 11/5/2019 07:54

Notice of Extraordinary General Meeting and Shareholders’ Circular

London: Friday, May 3, 2019: Hutchison China MediTech Limited (“Chi-Med̶1; or “Company”;) (AIM/Nasdaq: HCM) today announces that an Extraordinary General Meeting (“EGM”) is to be held at 11:00 a.m. London time on Wednesday, May 29, 2019. An explanatory circular and a form of proxy have been posted to shareholders.

[sportii] 11/5/2019 05:38

Few years ago, I was holding ‘PACE’ shares. When PACE was acquired by an American company, I was offered equivalent numbers of the American company’s shares. My stockbrokers, at that time, were not able to hold foreign listed company shares in their nominee accounts. They arranged to transfer my shares to a different Uk based stock brokerage who could. But, I had to move the shares outside the ISA bracket as foreign listed shares were not allowed in ISA stocks account in the new brokerage firm. Not sure if similar rules still apply. Private investors can check with their stockbrokers.
But, what are the chances of HCM closing it’s AIM listing? A large number of institutional investors and many directors are holding AIM shares. Is ‘low volumes’ a sufficient reason for giving up London stock exchange listing? Has the management ever mentioned in its statements or meetings?

[lauders] 11/5/2019 01:10

If you are correct I am not sure how that would affect holdings in HCM on AIM where shareholders who only have UK accounts are concerned. It will all be thought out I am sure but would that likely mean having to sell the shares? Something that my broker (Selftrade) would have to provide guidance on. The prospect doesn't exactly excite me! I was planning to buy back what I topped-sliced at some point, but not so certain now.

[steeplejack] 10/5/2019 21:24

You could be right.The low volume in London doesn't merit the cost of a listing.GW Pharmaceuticals abandoned an AIM listing a year or so back.

[nerdofsteel] 10/5/2019 19:48

NEW YORK, May 9, 2019 /PRNewswire/ -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on May 15th and 16th, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Representatives from participating companies based in Germany, Norway, Denmark, China, Switzerland, Australia, Brazil and the UK will respond to questions during formal presentations, and will also interact with investors via virtual trade booths. The conference is targeted to all types of investors as well as analysts interested in non-US companies.

There is no fee for participants to log in, attend live presentations or ask questions.

To register, please use the following link: www.adr.db.com/dbvic

Pre-registration is suggested to save time.

May 15th Agenda (US Eastern Standard Time):

8:30 AM: First Pacific (Hong Kong: 142, OTC Pink: FPAFY)
9:00 AM: Subsea 7 (Norway: SUBC, OTC Pink: SUBCY)
9:30 AM: Lufthansa (Germany: LHA, OTCQX: DLAKY)
10:00 AM: Hutchison China MediTech (LONDON AIM: HCM, NASDAQ: HCM)

[nerdofsteel] 10/5/2019 19:39

I think the Company will (hopefully) de-list from AIM in the next year or two. Once they have a HK listing as well as NASDAQ I see no point in the London listing. AIM and the London market in general have no idea as to how to value Biotech and Biopharma and the original reasons for the London listing are no longer relevant in my opinion.

[steeplejack] 09/5/2019 21:05

So it looks like HCM has become a proxy of sorts for the success or otherwise of China trade talks.This has eclipsed the excitement that might have been fuelled by an HK listing.I like this stock but the considerable volatility makes you recognise that for all the immense potential,this is an AIM listed company and has a nasty tendency to behave like one.Best really to tuck them away and forget about extreme price moves but we all know that's easier said than done.Left the stock around £39-50 equivalent.

[cisk] 09/5/2019 16:45

I might be tempted to add a few more at these levels. Can anyone summarize when and what the listing changes are?

[lauders] 09/5/2019 16:38

I would agree with the China sentiment angle steeplejack. Have to admit to taking some off the table (small percentage of my holding) because of the situation on the hope I can add lower down. So far it seems to be working but I am in no hurry to get back in at present. The rest I left as a "core holding" come what will as they say! Not sure if the HK listing is going to bring any stability or just add to the ups and downs! Listed on three exchanges must be a negative in some respects. Wonder if the positives outweigh the negatives?

[steeplejack] 09/5/2019 16:12

Slumping in the US,down 10% to $26-40.US healthcare weak in general.China trade talks probably hitting sentiment.

[lauders] 06/5/2019 03:42

I see the newly adjusted share price will coincide with this HK event:



Could be interesting? Or, I may be reading too much into it ;-)

[nerdofsteel] 03/5/2019 09:29

;o-)

Also, here is Trinity Delta's perspective on the HK listing

[grupo] 03/5/2019 09:20

Nerdofsteel
3 May '19 - 08:15 - 1886 of 1887
0 0 0


Proposed new Articles of Association

I wonder if next Years AGM will be held in Hong Kong? I look forward to attending wherever it may be.


cheers nerd

caps to start link and then no kisses

[nerdofsteel] 03/5/2019 09:02

"Although the existing ordinary shares of the Company have a par value of US$1.00 each (“Existing Ordinary Shares”), the average market price per Existing Ordinary Share during the past 12 months has exceeded £40. As at 29 April 2019
(being the latest practicable date prior to publication of this letter), the Company’s issued share capital was US$66,657,745 comprising 66,657,745 Existing Ordinary Shares with a market capitalisation of approximately £3 billion.
The Board believes that in anticipation of the SEHK Listing and the Offering (as more particularly described in the Company’s RIS announcement on 15 April 2019), the Subdivision of each Existing Ordinary Share of US$1.00 each into 10 New
Ordinary Shares of US$0.10 each would benefi t all Shareholders and make the Company’s shares more accessible to smaller investors, including the Company’s employees who are participants of the Company’s share schemes. The Subdivision may also improve liquidity of the market in the Company’s shares and reduce in percentage terms the bid/offer spread in the Company’s shares"

[nerdofsteel] 03/5/2019 08:15

hxxps://www.chi-med.com/wp-content/uploads/2019/05/Mem190503.pdf

Proposed new Articles of Association

I wonder if next Years AGM will be held in Hong Kong? I look forward to attending wherever it may be.

[waldron] 01/5/2019 08:24

cheers
fella

Nerdofsteel
1 May '19 - 07:07 - 1884 of 1884
0 1 0
Chi-Med's pipeline was recently updated and can be located on the Company's website:-